Top Markets
Coin of the day
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Classement en actions #40696
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Prix de l'action
$0.0121
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$97.54K
Changement (1 jour)
-24.38%
Changement (1 an)
0.00%
Pays
US
Échange Gelesis Holdings, Inc. (GLS)

Catégorie

Historique du rendement du dividende pour Gelesis Holdings, Inc. (GLS)
Le rendement du dividende (TTM) de Gelesis Holdings, Inc. (symbole boursier : GLS) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Gelesis Holdings, Inc. (GLS) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE